東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Antiprotozoal drug development and d...

Vermelho, Alane Beatriz.

Linked to FindBook

Google Book

Amazon

博客來

Antiprotozoal drug development and delivery

Record Type:	Electronic resources : Monograph/item
Title/Author:	Antiprotozoal drug development and delivery/ edited by Alane Beatriz Vermelho, Claudiu T. Supuran.
other author:	Vermelho, Alane Beatriz.
Published:	Cham :Springer International Publishing : : 2022.,
Description:	x, 331 p. :ill., digital ;24 cm.
[NT 15003449]:	Classical and Modern Drug Treatments for Leishmaniasis -- Saponins as Potential Antiprotozoa Agents -- Chagas Disease: Drug Development and Parasite Target -- Targeting carbonic anhydrases from Leishmania spp. and Trypanosoma cruzi as a strategy to obtain new drugs -- New Compounds for the Management of Trypanosoma brucei Infection -- Polyamine and Trypanothione Pathways as Targets for Novel Antileishmanial Drugs -- Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs -- Pharmacological Treatment of Malaria -- η-Class Carbonic Anhydrases as Antiplasmodial Drug Targets: Current State of the Art and Hurdles to Develop New Antimalarials -- Management of Entamoeba histolytica Infection: Treatment Strategies and Possible New Drug Targets -- Trichomonas vaginalis Pharmacological Treatment -- Beta-Carbonic Anhydrase from Trichomonas Vaginalis as New Antiprotozoan Drug Target -- Drugs for the treatment of toxoplasmosis -- Challenges and promises for obtaining new antiprotozoal drugs - what's going wrong?
Contained By:	Springer Nature eBook
Subject:	Tropical medicine. -
Online resource:	https://doi.org/10.1007/978-3-031-06850-8
ISBN:	9783031068508

Antiprotozoal drug development and delivery
Antiprotozoal drug development and delivery[electronic resource] /edited by Alane Beatriz Vermelho, Claudiu T. Supuran. - Cham :Springer International Publishing :2022. - x, 331 p. :ill., digital ;24 cm. - Topics in medicinal chemistry,v. 391862-247X ;. - Topics in medicinal chemistry ;v. 39..

Classical and Modern Drug Treatments for Leishmaniasis -- Saponins as Potential Antiprotozoa Agents -- Chagas Disease: Drug Development and Parasite Target -- Targeting carbonic anhydrases from Leishmania spp. and Trypanosoma cruzi as a strategy to obtain new drugs -- New Compounds for the Management of Trypanosoma brucei Infection -- Polyamine and Trypanothione Pathways as Targets for Novel Antileishmanial Drugs -- Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs -- Pharmacological Treatment of Malaria -- η-Class Carbonic Anhydrases as Antiplasmodial Drug Targets: Current State of the Art and Hurdles to Develop New Antimalarials -- Management of Entamoeba histolytica Infection: Treatment Strategies and Possible New Drug Targets -- Trichomonas vaginalis Pharmacological Treatment -- Beta-Carbonic Anhydrase from Trichomonas Vaginalis as New Antiprotozoan Drug Target -- Drugs for the treatment of toxoplasmosis -- Challenges and promises for obtaining new antiprotozoal drugs - what's going wrong?

This book reviews new promising drug targets for Neglected Tropical Diseases (NTDs), with a special focus on antiprotozoal drugs against trpyanosomatids Trypanosoma cruzi and Leishmania spp. The book offers a comprehensive overview of the most recent studied targets, and it outlines classical and new treatments and delivery strategies. Expert contributors describe new methods of analysis and bio-prospecting for new compounds, and provide a critical perspective of the translational process used in the research and development of new drug candidates. The book will appeal not only to researchers, students and professionals interested in drug development to protozoan diseases, but also to medicinal chemists in general.

ISBN: 9783031068508

Standard No.: 10.1007/978-3-031-06850-8doiSubjects--Topical Terms:

772377
Tropical medicine.

LC Class. No.: RC961.5 / .A57 2022

Dewey Class. No.: 616.9883

Antiprotozoal drug development and delivery
LDR:02914nmm a2200361 a 4500 001 2301779
003 DE-He213
005 20220624213007.0
006 m d
007 cr nn 008maaau
008 230409s2022 sz s 0 eng d
020 $a 9783031068508 $q (electronic bk.)
020 $a 9783031068492 $q (paper)
024 7 $a 10.1007/978-3-031-06850-8 $2 doi
035 $a 978-3-031-06850-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC961.5 $b .A57 2022
072 7 $a PNN $2 bicssc
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 616.9883 $2 23
090 $a RC961.5 $b .A633 2022
245 0 0 $a Antiprotozoal drug development and delivery $h [electronic resource] / $c edited by Alane Beatriz Vermelho, Claudiu T. Supuran.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a x, 331 p. : $b ill., digital ; $c 24 cm.
338 $a online resource $b cr $2 rdacarrier
490 1 $a Topics in medicinal chemistry, $x 1862-247X ; $v v. 39
505 0 $a Classical and Modern Drug Treatments for Leishmaniasis -- Saponins as Potential Antiprotozoa Agents -- Chagas Disease: Drug Development and Parasite Target -- Targeting carbonic anhydrases from Leishmania spp. and Trypanosoma cruzi as a strategy to obtain new drugs -- New Compounds for the Management of Trypanosoma brucei Infection -- Polyamine and Trypanothione Pathways as Targets for Novel Antileishmanial Drugs -- Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs -- Pharmacological Treatment of Malaria -- η-Class Carbonic Anhydrases as Antiplasmodial Drug Targets: Current State of the Art and Hurdles to Develop New Antimalarials -- Management of Entamoeba histolytica Infection: Treatment Strategies and Possible New Drug Targets -- Trichomonas vaginalis Pharmacological Treatment -- Beta-Carbonic Anhydrase from Trichomonas Vaginalis as New Antiprotozoan Drug Target -- Drugs for the treatment of toxoplasmosis -- Challenges and promises for obtaining new antiprotozoal drugs - what's going wrong?
520 $a This book reviews new promising drug targets for Neglected Tropical Diseases (NTDs), with a special focus on antiprotozoal drugs against trpyanosomatids Trypanosoma cruzi and Leishmania spp. The book offers a comprehensive overview of the most recent studied targets, and it outlines classical and new treatments and delivery strategies. Expert contributors describe new methods of analysis and bio-prospecting for new compounds, and provide a critical perspective of the translational process used in the research and development of new drug candidates. The book will appeal not only to researchers, students and professionals interested in drug development to protozoan diseases, but also to medicinal chemists in general.
650 0 $a Tropical medicine. $3 772377
650 0 $a Drug development. $3 716904
650 0 $a Antiprotozoal agents. $3 923492
650 1 4 $a Medicinal Chemistry. $3 892420
650 2 4 $a Synthetic Biology. $3 2046201
650 2 4 $a Medical Microbiology. $3 890951
650 2 4 $a Parasitology. $3 635062
650 2 4 $a Health Promotion and Disease Prevention. $3 894308
650 2 4 $a Computational and Systems Biology. $3 3531279
700 1 $a Vermelho, Alane Beatriz. $3 3601502
700 1 $a Supuran, Claudiu T. $3 3218078
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Topics in medicinal chemistry ; $v v. 39. $3 3601503
856 4 0 $u https://doi.org/10.1007/978-3-031-06850-8
950 $a Chemistry and Materials Science (SpringerNature-11644)